Skip to main content
. 2022 Jan 21;12:730940. doi: 10.3389/fneur.2021.730940

Table 1.

Baseline characteristics of patients with sICH and without sICH.

No. Total Patients (n = 369) sICH group (n = 62) Non-sICH group (n = 307) P-value
Age (y) 66 (57, 74) 68 (59, 75) 65 (57, 74) 0.224
Gender, male, n (%) 250 (67.8) 38 (61.3) 212 (69.1) 0.233
BMI (kg/m2) 24.91 (22.86, 27.34) 24.75 (22.05, 27.19) 24.97 (23.03, 27.34) 0.347
Medical history, n (%)
   Smoking 115 (31.2) 16 (25.8) 99 (32.2) 0.318
   Drinking 102 (27.6) 14 (22.6) 88 (28.7) 0.329
   Hypertension 252 (68.3) 42 (67.7) 210 (68.4) 0.919
   Hyperlipemia 95 (25.7) 13 (21.0) 82 (26.7) 0.346
   Diabetes 108 (29.3) 28 (45.2) 80 (26.1) 0.003
   Atrial fibrillation 97 (26.3) 21 (33.9) 76 (24.8) 0.137
   Previous stroke 109 (29.5) 21 (33.9) 88 (28.7) 0.412
   Coronary heart disease 89 (24.1) 17 (27.4) 72 (23.5) 0.505
Blood pressure at admission (mmHg)
   SBP 150 (135, 167) 159 (136, 171) 150 (135, 165) 0.182
   DBP 85 (78, 92) 86 (80, 93) 84 (78, 92) 0.525
Related scores
   Pre-stroke mRS score 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.195
   ASPECTS score at admission 8 (7, 9) 8 (7, 9) 8 (7, 10) 0.008
   NIHSS score at admission 15 (12, 19) 16 (12, 20) 15 (12, 19) 0.198
Laboratory data
   FBG (mmol/L) 7.2 (6.0, 9.3) 8.1 (7.0, 12.7) 7.1 (5.9, 9.0) <0.001
   WBC (× 109/L) 8.9 (7.1, 11.0) 9.0 (6.8, 11.3) 9.2 (7.3, 11.1) 0.973
   NLR 5.95 (3.38, 9.68) 6.48 (4.02, 9.36) 5.80 (3.08, 10.08) 0.038
   PLT (× 109/L) 212 (172, 252) 199 (159, 246) 223 (181, 264) 0.033
   TT (s) 16.0 (15.3, 17.0) 16.4 (15.4, 17.2) 15.9 (15.2, 16.5) 0.013
   Albumin (g/L) 40.3 (38.0, 42.7) 40.8 (39.1, 42.9) 40.8 (38.5, 43.1) 0.458
   TC (mmol/L) 4.44 (3.69, 5.09) 4.61 (3.83, 5.27) 4.43 (3.65, 5.06) 0.740
   TG (mmol/L) 1.19 (0.79, 1.81) 1.18 (0.73, 2.05) 1.19 (0.80, 1.83) 0.934
   LDL (mmol/L) 2.78 (2.07, 3.46) 2.94 (2.22, 3.67) 2.77 (2.07, 3.46) 0.799
Stroke subtype: TOAST, n (%) 0.411
   LAA 257 (69.6) 40 (64.5) 217 (70.7)
   CE 95 (25.7) 20 (32.3) 75 (24.4)
   Other subtype 17 (4.6) 2 (3.2) 15 (4.9)

sICH, symptomatic intracranial hemorrhage; BMI, Body Mass Index; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; mRS, modified Rankin scale; APSECTS, Alberta Stroke Program Early Computed Tomography score; NIHSS, National Institutes of Health Stroke Scale; FBG, Fasting blood glucose; WBC, White blood cell; NLR, Neutrophil to lymphocyte ratio; PLT, Platelets; TT, Thrombin time; TC, Total cholesterol; TG, Triglyceride; LDL, Low-density lipoprotein; TOAST: Trial of Org 10172 in Acute Stroke Treatment; LAA, Large-artery atherosclerosis; CE, Cardioembolism.